Frontiers in Immunology | Vaccines and Molecular Therapeutics

Original Research

Published on 24 May 2023

SARS-CoV-2 bivalent mRNA vaccine with broad protection against variants of concern

in Vaccines and Molecular Therapeutics

Qinhai Ma
Man Li
Lin Ma
Caroline Zhang
Hong Zhang
Huiling Zhong
Jian Wen
Yongsheng Wang
Zewei Yan
Wei Xiong

Frontiers in Immunology

doi 10.3389/fimmu.2023.1195299

6,470 views
9 citations

Correction

Published on 24 May 2023

Corrigendum: The impact of circadian rhythm on Bacillus Calmette-Guérin vaccination effects on SARS-CoV-2 infections

in Vaccines and Molecular Therapeutics

Konstantin Föhse
Esther J. M. Taks
Simone J. C. F. M. Moorlag
Marc J. M. Bonten
Reinout van Crevel
Jaap ten Oever
Cornelis H. van Werkhoven
Mihai G. Netea
Josephine S. van de Maat
Jacobien J. Hoogerwerf

Frontiers in Immunology

doi 10.3389/fimmu.2023.1208659

1,524 views

Opinion

Published on 23 May 2023

Two issues should be noted when designing a clinical trial to evaluate BCG effects on COVID-19

in Vaccines and Molecular Therapeutics

Wenping Gong
Yinping Liu
Yong Xue
Li Zhuang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1207212

1,737 views
6 citations

Review

Published on 23 May 2023

SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines

in Vaccines and Molecular Therapeutics

Shanti Pather
Shabir A. Madhi
Benjamin J. Cowling
Paul Moss
Jeremy P. Kamil
Sandra Ciesek
Alexander Muik
Özlem Türeci

Frontiers in Immunology

doi 10.3389/fimmu.2023.1130539

10,824 views
59 citations

Original Research

Published on 22 May 2023

High immunogenicity of virus-like particles (VLPs) decorated with Aeromonas salmonicida VapA antigen in rainbow trout

in Vaccines and Molecular Therapeutics

Jeong In Yang
Dagoberto Sepúlveda
Irina Vardia
Jakob Skov
Louise Goksøyr
Adam F. Sander
Niels Lorenzen

Frontiers in Immunology

doi 10.3389/fimmu.2023.1139206

5,738 views
6 citations

Original Research

Published on 19 May 2023

A tetravalent nanoparticle vaccine elicits a balanced and potent immune response against dengue viruses without inducing antibody-dependent enhancement

in Vaccines and Molecular Therapeutics

Qier Chen
Rong Li
Bolin Wu
Xu Zhang
Hui Zhang
Ran Chen

Frontiers in Immunology

doi 10.3389/fimmu.2023.1193175

6,558 views
11 citations

Brief Research Report

Published on 19 May 2023

Enhancing immune protection against MERS-CoV: the synergistic effect of proteolytic cleavage sites and the fusion peptide and RBD domain targeting VLP immunization

in Vaccines and Molecular Therapeutics

Jeein Oh
Uni Park
Juhyung Kim
Kyeongseok Jeon
Chulwoo Kim
Nam-Hyuk Cho
Youn Soo Choi

Frontiers in Immunology

doi 10.3389/fimmu.2023.1201136

3,318 views
1 citation

Original Research

Published on 18 May 2023

Systemic priming and intranasal booster with a BcfA-adjuvanted acellular pertussis vaccine generates CD4+ IL-17+ nasal tissue resident T cells and reduces B. pertussis nasal colonization

in Vaccines and Molecular Therapeutics

Kacy S. Yount
Jesse M. Hall
Kyle Caution
Mohamed M. Shamseldin
Myra Guo
Keirsten Marion
Audra R. Fullen
Yimin Huang
Jennifer A. Maynard
Sally A. Quataert

Frontiers in Immunology

doi 10.3389/fimmu.2023.1181876

5,298 views
10 citations

Original Research

Published on 18 May 2023

Production of monoclonal antibody of heat-labile toxin A subunit to identify enterotoxigenic Escherichia coli by epitope mapping using synthetic peptides

in Vaccines and Molecular Therapeutics

Jun-Young Park
Seung-Hak Cho

Frontiers in Immunology

doi 10.3389/fimmu.2023.1152910

2,735 views
1 citation

Original Research

Published on 17 May 2023

Antibody response and safety of inactivated SARS-CoV-2 vaccines in chronic hepatitis B patients with and without cirrhosis

in Vaccines and Molecular Therapeutics

Huanhuan Cao
Yufei Huang
Chunxiu Zhong
Xingmei Liao
Wenjuan Tan
Siru Zhao
Liangxu Guo
Rong Fan

Frontiers in Immunology

doi 10.3389/fimmu.2023.1167533

2,732 views
3 citations

Original Research

Published on 17 May 2023

Analysis and comparison of SARS-CoV-2 variant antibodies and neutralizing activity for 6 months after a booster mRNA vaccine in a healthcare worker population

in Vaccines and Molecular Therapeutics

Sina Hosseinian
Rafael de Assis
Ghali Khalil
Madeleine K. Luu
Aarti Jain
Peter Horvath
Rie Nakajima
Anton M. Palma
Anthony Hoang
Eisa Razzak

Frontiers in Immunology

doi 10.3389/fimmu.2023.1166261

2,498 views
8 citations

Review

Published on 15 May 2023

Monoclonal antibodies for prophylaxis and therapy of respiratory syncytial virus, SARS-CoV-2, human immunodeficiency virus, rabies and bacterial infections: an update from the World Association of Infectious Diseases and Immunological Disorders and the Italian Society of Antinfective Therapy

in Vaccines and Molecular Therapeutics

Susanna Esposito
Gayatri Amirthalingam
Matteo Bassetti
Francesco Blasi
Francesco Giuseppe De Rosa
Natasha B. Halasa
Ivan Hung
Albert Osterhaus
Tina Tan
Juan Pablo Torres

Frontiers in Immunology

doi 10.3389/fimmu.2023.1162342

14,370 views
24 citations

Original Research

Published on 15 May 2023

Adenoviral-vectored epigraph vaccine elicits robust, durable, and protective immunity against H3 influenza A virus in swine

in Vaccines and Molecular Therapeutics

Erika Petro-Turnquist
Matthew Pekarek
Nicholas Jeanjaquet
Cedric Wooledge
David Steffen
Hiep Vu
Eric A. Weaver

Frontiers in Immunology

doi 10.3389/fimmu.2023.1143451

7,897 views
12 citations

Original Research

Published on 12 May 2023

Biomarkers detected in cord blood predict vaccine responses in young infants

in Vaccines and Molecular Therapeutics

Carolyn H. Baloh
Guglielmo M. Venturi
Bernard M. Fischer
Liane S. Sadder
Julie J. Kim-Chang
Cliburn Chan
Kristina De Paris
Li Yin
Grace M. Aldrovandi
Maureen M. Goodenow

Frontiers in Immunology

doi 10.3389/fimmu.2023.1152538

3,992 views
6 citations

Brief Research Report

Published on 12 May 2023

Heterologous vaccination with inactivated vaccine and mRNA vaccine augments antibodies against both spike and nucleocapsid proteins of SARS-CoV-2: a local study in Macao

in Vaccines and Molecular Therapeutics

Hoi Man Ng
Chon Lok Lei
Siyi Fu
Enqin Li
Sek In Leong
Chu Iong Nip
Nga Man Choi
Kai Seng Lai
Xi Jun Tang
Chon Leng Lei

Frontiers in Immunology

doi 10.3389/fimmu.2023.1131985

2,718 views
5 citations

Review

Published on 12 May 2023

Human papillomavirus vaccination in low- and middle-income countries: progression, barriers, and future prospective

in Vaccines and Molecular Therapeutics

Narges Ebrahimi
Zahra Yousefi
Gholamreza Khosravi
Fatemeh Eskandari Malayeri
Marjan Golabi
Monireh Askarzadeh
Mohammad Hossein Shams
Behrooz Ghezelbash
Nahid Eskandari

Frontiers in Immunology

doi 10.3389/fimmu.2023.1150238

22,251 views
81 citations